ADXN — Addex Therapeutics Ltd.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1574232 ·
Last close
$3.50
Market Cap
$4.43M
52W High
$10.43
52W Low
$2.56
ADV30
772,241
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 — -645,352 -1,744,679 3,481,302 767,328 1,572,744
Mar 2026 0 — -479,827 -1,711,739 4,759,193 935,153 1,472,531
Dec 2025 248 — -779,263 -1,836,987 6,364,272 1,638,612 1,597,580
Sep 2025 29,724 — -696,175 -1,577,231 7,330,802 2,187,202 1,372,247

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-2,386,671
Investing CF
$56,669
Financing CF
$791,811
CapEx
—
Dividends Paid
$0
Buybacks
$-21,813
EPS Diluted TTM
$-6.00
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-363,547,119
Inventory
—
Receivables
$29,746
ST Investments
$3,984
EBIT TTM
$-6,864,053
Pretax Income TTM
$-6,867,231
Interest Exp TTM
$3,178
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$109,496
EBITDA
$-2,689,751
Free Cash Flow
$-1,524,704
Enterprise Value
$2,637,307
Total Cash
$935,153
Total Debt
$102,269
Shares Out
1,265,844
Trailing EPS
$-8.89
Book Value
$4.12
ROE
-122.3%
ROA
-23.6%
Div Yield
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 29,972 -2,814,598 -6,728,246 6,364,272 1,597,580 4,766,692 -2,171,117
Dec 2024 404,102 -2,755,233 7,055,787 10,678,303 1,001,032 9,677,271 -5,373,554
Dec 2023 1,612,953 -2,242,967 -10,556,227 4,641,885 3,496,420 1,145,465 -7,992,411
Dec 2022 1,422,438 -10,540,901 -20,804,213 8,282,050 3,369,139 4,912,911 -16,437,185
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.05

Peers — same industry

TickerNameMarket CapLastDaily %
SKYE Skye Bioscience, Inc. $4.43M $1.00 —
TCRT Alaunos Therapeutics, Inc. $4.22M $1.66 —
LTRN Lantern Pharma Inc. $4.67M $0.37 —
KPRX KIORA PHARMACEUTICALS INC $4.11M $0.93 —
CNSY CERENOME, INC. $4.78M $0.63 —

News headlines (Yahoo Finance, 1h cache)

Addex Spin-out Neurosterix Closes $105 Million Series B Financing
2026-11-11 21:32 · Yahoo
ADDEX INCREASES ISSUED SHARE CAPITAL TO CREATE TREASURY SHARES
2026-10-29 06:00 · Yahoo
Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies of NTX-253 for Schizophrenia
2026-10-08 05:00 · Yahoo
Addex Therapeutics Announces Executive Management Changes
2026-10-02 05:00 · Yahoo
Addex (ADXN) Q2 2026 Earnings Call Transcript
2026-09-29 02:43 · Yahoo
Addex Therapeutics Reports 2026 Half-Year Results and Provides Corporate Update
2026-09-28 05:00 · Yahoo
Addex Regains Rights to GABAB Positive Allosteric Modulator Portfolio from Indivior
2026-09-25 05:00 · Yahoo
Addex Therapeutics to Report 2026 Half-Year Financial Results and Host Conference Call on September 28, 2026
2026-09-24 05:00 · Yahoo
ADDEX raises USD 2.8 million through its ATM agreement and extends cash runway to the fourth quarter 2027
2026-08-26 05:00 · Yahoo
Novo submits sickle cell drug; Flagship, Gates Foundation deepen ties
2026-11-13 14:36 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.